Keyword: cardiovascular drugs
News
08.01.2024
-
Bayer and RTW Investments have announced an equity investment in Jixing Pharmaceuticals of €32 million ($35 million) and €116 million ($127 million) respectively.
News
11.07.2013
- Roche will halt development of a diabetes drug partly because of its undesired side-effects, marking another high-profile setback for the Swiss company as it struggles to diversify...
News
07.05.2012
- Swiss drugmaker Roche has ended efforts to develop a heart disease drug which some industry analysts had estimated could have achieved $10 billion in annual sales, after poor...
